Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ormont Drug and Chemical was a pharmaceutical company primarily active in the mid-20th century, specializing in the manufacture and distribution of specialty and generic drugs. The company was widely recognized for its Panray division, which was a leading provider of antitubercular medications, most notably isoniazid, in the United States. Additionally, its Parlam division focused on the veterinary medicine market, providing a range of therapeutic agents for animal health. Headquartered in New Jersey, Ormont operated as a publicly traded entity before its acquisition by The Purdue Frederick Company (now known as Purdue Pharma) in 1982. The firm played a significant role in the treatment of infectious diseases and the growth of the generic pharmaceutical industry during its decades of operation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ormont Drug and Chemical.